SITC Cancer Immunotherapy CONNECT

2021 SITC Logo Crop

SITC 2021 Virtual Platform
Both in-person and virtual participants of the 36th Annual Meeting & Pre-Conference Programs (SITC 2021) can now access the SITC 2021 virtual website. Log in using the email address used to register and your confirmation number.

2021 SITC Logo Crop

Now Available
Regular and YIA Abstract Titles and Authors
With a record-breaking number of abstract submissions, SITC is excited to announce titles and authors for regular and Young Investigator Award (YIA) abstracts and posters that will be presented at the upcoming 36th Annual Meeting.

Log in to an upcoming Advances in Cancer Immunotherapy™ Live Virtual Program!
Dec. 14 ACI: A Focus on Gynecologic Cancers
Dec. 18 ACI: A Focus on Cell Therapies and T Cell Engagers
Jan. 12 ACI: A Focus on Head and Neck Cancers
Jan. 27 ACI: A Focus on Intratumoral Therapies, Vaccines, and Cytokines


SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines (CPG) Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring guideline content and expert panel recommendations in an easy-to-navigate format. The app includes interactive tools, bookmarks, and advanced search capabilities.
Available for FREE for iOS and Android.

Learn More


Cancer Immunotherapy Winter School, Jan. 24–28, 2022

SITC is pleased to host its fourth annual and first hybrid Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, Jan. 24–28, 2022.

Register Today

New SITC Clinical Practice Guidelines Published

  • Acute Leukemia
  • Breast Cancer
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitor-related Adverse Events
  • Urothelial Cancer
Free companion educational webinars available.


JITC Increases Impact Factor to 13.751
The Journal for ImmunoTherapy of Cancer's (JITC) Impact Factor makes JITC the highest ranked fully open access immunology journal and places it in the top 5% percent of all journals published in the category of immunology and top 7% in the category of oncology.


Targets for Cancer Immunotherapy: A Deep Dive

A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field. 



JITC Special Series: COVID-19 and Cancer Immunotherapy

Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.


Why I'm a SITC Member

Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


Immunotherapy for the Treatment of Breast and Gynecologic Cancers 

A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now

Consistent with the Safer at Home Order issued by the Department of Health Services of the State of Wisconsin, all SITC Executive Office staff will be working remotely beginning March 25, 2020, and are best reached through email. General inquiries can be sent to Thank you for understanding.


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Posted in: Women in SITC

    Hosted by Arthur and Sandra Irving, this working symposium will focus on advancing the careers of young scientists doing research in cancer immunology. ~15 accomplished faculty mentors will share their research career experience in cancer immunology with ...

  • Hi Todd, I just saw your message. If you can get a chapter to me by December 15th, this would work. My email is  Thanks, Priya ------------------------------ Priya Hays PhD Senior Technical Writer Personalis San Mateo CA -- ...

  • SITC community, I would like to announce the release of my book Advancing Healthcare Through Personalized Medicine, Second Edition by Springer Nature. The book has an in-depth discussion of precision oncology and cancer immunotherapies, among other topics ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More